Nine Monthly Results Results Snapshot
Figures in Rs cr
Standalone Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Nine Monthly Analysis Highlights
Net Sales
YoY Growth in nine months ended Dec 2024 is 27.21% vs -8.85% in Dec 2023
Standalone Net Profit
YoY Growth in nine months ended Dec 2024 is 157.96% vs -10.46% in Dec 2023
Operating Profit (PBDIT) excl Other Income
YoY Growth in nine months ended Dec 2024 is 107.75% vs -28.98% in Dec 2023
Interest
YoY Growth in nine months ended Dec 2024 is 16.67% vs 172.73% in Dec 2023
Operating Profit Margin (Excl OI)
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
Compare Nine Monthly Results Of Jagsonpal Pharma With
Figures in Rs cr
Standalone Nine Monthly Results
Change(INR)
Change(%)
Net Sales
210.16
7,329.57
-7,119.41
-97.13%
Other Operating Income
0.00
0.00
0.00
Total Operating income
210.16
7,329.57
-7,119.41
-97.13%
Raw Material Cost
14.86
566.08
-551.22
-97.37%
Purchase of Finished goods
63.19
1,433.87
-1,370.68
-95.59%
(Increase) / Decrease In Stocks
-2.86
49.31
-52.17
-105.80%
Employee Cost
49.49
1,569.75
-1,520.26
-96.85%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
43.12
1,645.40
-1,602.28
-97.38%
Total Expenditure (Excl Depreciation)
167.80
5,264.41
-5,096.61
-96.81%
Operating Profit (PBDIT) excl Other Income
42.36
2,065.16
-2,022.80
-97.95%
Other Income
5.42
270.41
-264.99
-98.00%
Operating Profit (PBDIT)
47.78
2,335.57
-2,287.79
-97.95%
Interest
0.70
207.65
-206.95
-99.66%
Exceptional Items
19.89
61.23
-41.34
-67.52%
Gross Profit (PBDT)
66.97
2,127.92
-2,060.95
-96.85%
Depreciation
5.82
255.85
-250.03
-97.73%
Profit Before Tax
61.15
1,872.07
-1,810.92
-96.73%
Tax
12.37
369.00
-356.63
-96.65%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
48.78
1,503.07
-1,454.29
-96.75%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
61.23
-61.23
-100.00%
Net Profit
48.78
1,564.30
-1,515.52
-96.88%
Equity Capital
13.23
40.06
-26.83
-66.97%
Face Value
2.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
0.00
0.00
0.00
Operating Profit Margin (Excl OI)
20.16%
28.18%
0.00
-8.02%
Gross Profit Margin
31.87%
29.03%
0.00
2.84%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 210.16 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 27.21% vs -8.85% in Dec 2023
Nine Monthly - Standalone Net Profit
Standalone Net Profit 48.78 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 157.96% vs -10.46% in Dec 2023
Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 42.36 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 107.75% vs -28.98% in Dec 2023
Nine Monthly - Interest
Interest 0.70 Cr
in Dec 2024Figures in Rs Cr
YoY Growth in nine months ended Dec 2024 is 16.67% vs 172.73% in Dec 2023
Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.16%
in Dec 2024Figures in Rs %
YoY Growth in nine months ended Dec 2024 has improved from Dec 2023
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
